MEOX2 and lung carcinoma: In addition, quantitative validation and functional analyses confirmed that expression of the MEOX2-GLI1 transcriptional axis, accompanied by active RNA Pol II and the epigenetic activation histones H3K27Ac and H3K4me3, were involved in resistance to the cancer drug cisplatinum and lung cancer cell migration and proliferation.